Literature DB >> 18242471

What can be learned from the COURAGE trial?

George A Beller.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18242471     DOI: 10.1016/j.nuclcard.2007.11.015

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  4 in total

1.  COURAGE under fire: on the management of stable coronary disease.

Authors:  George A Diamond; Sanjay Kaul
Journal:  J Am Coll Cardiol       Date:  2007-09-17       Impact factor: 24.094

2.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

3.  Pioglitazone improves myocardial blood flow and glucose utilization in nondiabetic patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled study.

Authors:  Rossi P Naoumova; Heiko Kindler; Lucia Leccisotti; Marco Mongillo; Muhammad T Khan; Clare Neuwirth; Mary Seed; Paul Holvoet; John Betteridge; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

4.  The truth and consequences of the COURAGE trial.

Authors:  Dean J Kereiakes; Paul S Teirstein; Ian J Sarembock; David R Holmes; Mitchell W Krucoff; William W O'Neill; Ron Waksman; David O Williams; Jeffrey J Popma; Maurice Buchbinder; Roxana Mehran; Ian T Meredith; Jeffrey W Moses; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2007-09-17       Impact factor: 24.094

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.